Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Eden vs Wholesome Clinic

Two GLP-1 desks, one scoreboard. We put Eden and Wholesome Clinic head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 3 · Grade A−

Eden

Visit Eden Full brief →
vs
No. 128 · Grade C

Wholesome Clinic

Visit Wholesome Clinic Full brief →

The verdict

Eden takes this head-to-head.

Eden scores 91 to 71 on our six-factor Brief Score — A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.

That doesn't make Wholesome Clinic a bad call — it's best for readers who want multi-state telehealth pairing compounded glp-1 weight loss with integrative psychiatry. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
89
48
Supply Reliability
92
76
Transparency
93
88
Access Breadth
90
68
Clinical Oversight
92
81
Track Record
89
74
EdenBrief Score 91 · 71Wholesome Clinic

Price, coverage & the tracker

EdenWholesome Clinic
Brief Score91/100 (A−)71/100 (C)
Semaglutide$239/moFrom $109/mo (starting dose, compounded oral)
Tirzepatide$349/moFrom $249/mo (starting dose, compounded oral)
CoverageAll 50 states7 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

Eden: Premium line steady; high supply-chain disclosure keeps our confidence high.

Wholesome Clinic: New to the tracker on 1 August 2026. The published line reads From $109/mo (starting dose, compounded oral) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.